
CannaMetrix, LLC
The quality of our team
CannaMetrix Leadership

Harold C. Smith, Ph.D. Founder and CEO
-
32 years disease mechanism research, 15 years biotech drug development experience
-
Opinion leader in Epigenetics, 146 peer-reviewed publications
-
$16 M in Federal and Foundation Grant support, Bill and Melinda Gates funded Investigator
-
$6.8M raised as seed capital for OyaGen, Inc
-
Designed and established 6 laboratories since 1976 and directed operations at SUNY at Buffalo, Baylor College of Medicine, URMC Rochester and OyaGen, Inc
CannaMetrix Team

Charles Smith, Ph.D.
Scientist

Ryan Bennett, Ph.D.
Technical Consultant

Andrew K Gonsalves,
General Council

David Yule, Ph.D.
URMC
GPCR consultant

Mitch O’Connell, Ph.D.
URMC
Gene Editing Consultant

Luke Peppone, Ph.D.
URMC
Cannabis Clinical Trials
Consultant